Clinical Trials Sponsored by Medcin Instituto da Pele Ltda

Total 126 results

Farmoquimica S.A.
Medcin Instituto da Pele Ltda

Completed

Evaluation of the Effectiveness of the Anti-aging Effect of a Supplement in Improving Skin Conditions

Aging Well

Brazil
Farmoquimica S.A.
Medcin Instituto da Pele

Completed

Evaluation of Acceptability, Skin Barrier Restoration and Balance of Atopic Skin Using Moisturizer

Atopic Dermatitis

Brazil
Silimed Industria de Implantes Ltda
Medcin Instituto da Pele Ltda

Completed

Evaluation of the Safety and Effectiveness of the Investigational Product in Improvement of the Appearance of Wrinkles and General Aspect of the Skin

Skin Aging

Brazil
Biolab Sanus Farmaceutica
Medcin Instituto da Pele

Not yet recruiting

Stryphnodendron Adstringens Intimate Soap

Vaginal Flora Imbalance

Brazil
Federal University of São Paulo
Medcin Instituto da Pele Ltda

Completed

The Efficacy of an Oral Probiotic Associated With a Fixed Combination of Benzoyl Peroxide and Adapalene in the Treatment of Acne

Acne Vulgaris

Brazil
University of Sao Paulo General Hospital
Samsung Eletrônica da Amazônia Ltda; Academic Research Organization of Instituto...

Recruiting

Assessment of Smartwatch SAMSUNG to Monitor Sleep Quality: an Observational Prospective Study - SleepEx2 Protocol (SLEEP-EX2)

Insomnia | Sleep Initiation and Maintenance Disorders | Sleep | Health Status | Wearable Electronic Devices

Brazil
Professor Fernando Figueira Integral Medicine Institute
Universidade Estadual da Paraiba

Completed

Impact of Active Video Game on Cardiorespiratory, Macro and Microcirculation Function of Adolescents With Overweight

Physical Activity | Overweight and Obesity | Cardiovascular Risk Factor

Brazil
Professor Fernando Figueira Integral Medicine Institute
Universidade Estadual da Paraiba

Completed

Strength Training for Elderlies and Their Effects on Muscle Fatigue and Microcirculation - Randomized Clinical Trial

Aging
University of Sao Paulo General Hospital
Hospital Israelita Albert Einstein; Instituto Dante Pazzanese de Cardiologia; Beneficência Portuguesa de São Paulo and other collaborators

Completed

The REPLICCAR Registry and The Statewide Quality Improvement Initiative (REPLICCAR)

Cardiac Surgical Procedures

Brazil
InCor Heart Institute
Impulse Dynamics; I2medi Comercial Medica LTDA

Recruiting

Cardiac Contractility Modulation in Chagas Heart Disease (FIX-Chagas)

Heart Failure | Chagas Cardiomyopathy | Systolic Dysfunction | Right Bundle Branch Block and Left Anterior Fascicular Block | Right Bundle Branch Block and Left Posterior Fascicular Block

Brazil
Vaxine Pty Ltd
Australian Respiratory and Sleep Medicine Institute Ltd

Not yet recruiting

Covid-19 and Influenza Oral Vaccine Study

Influenza, Human | covid19 Infection

Australia
Cristália Produtos Químicos Farmacêuticos Ltda.
Professor Fernando Figueira Integral Medicine Institute

Withdrawn

Use of Lipid Emulsion or Nanoemulsion of Propofol on Children Undergoing Ambulatory Invasive Procedures.

Leukemia
Hubei Biological Medicine Industrial Technology...

Recruiting

A Study to Explore the Efficacy and Safety of HWH486 in Adults With Chronic Spontaneous Urticaria

Chronic Spontaneous Urticaria

China
Hubei Biological Medicine Industrial Technology...

Unknown

Phase I Clinical Study of HWH340 Tablet in Patients With Advanced Solid Tumors

Advanced Solid Tumors | HRD | BRCA Mutation

China
Vaxine Pty Ltd
Cinnagen; Australian Respiratory and Sleep Medicine Institute Ltd

Active, not recruiting

Booster Study of SpikoGen COVID-19 Vaccine

COVID-19

Australia
Universidade do Porto
Unidade Local de Saúde de Matosinhos, EPE; Instituto de Saude Publica da Universidade... and other collaborators

Not yet recruiting

Improving the Referral of Patients With Suspected Cognitive Impairment and Early Dementia (DemRefImprov)

Cognitive Dysfunction | Mild Cognitive Impairment

Portugal
Vaxine Pty Ltd
Australian Respiratory and Sleep Medicine Institute

Recruiting

Autologous Tumour Vaccine Trial

Solid Tumor

Australia
Vaxine Pty Ltd
Australian Respiratory and Sleep Medicine Institute

Not yet recruiting

A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection (HBV003)

Chronic Hepatitis b

Australia
Vaxine Pty Ltd
Australian Respiratory and Sleep Medicine Institute

Active, not recruiting

A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)

COVID-19

Australia
Vaxine Pty Ltd
Australian Respiratory and Sleep Medicine Institute

Completed

Recombinant H7 Hemagglutinin Influenza Vaccine Trial (FLU007)

Influenza, Avian

Australia
Jiangsu Cancer Institute & Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma
Jules Bordet Institute
Hospital de Clinicas de Porto Alegre; Hospital do Cancer, Sao Paulo; Feculdade...

Completed

FRAGRANCE Part A Safety: Study to Find a Genetic Signature of de Novo Resistance to Letrozole

Breast Cancer

Belgium
Associacao para Investigacao e Desenvolvimento...
University of Lisbon; Fundação para a Ciência e a Tecnologia; Instituto Politécnico...

Recruiting

Influence of Nutrition in Depression Treatment (INDEPT) (INDEPT)

Major Depressive Disorder - MDD

Portugal
Shandong Cancer Hospital and Institute
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC)

Triple Negative Breast Cancer

China
Vaxine Pty Ltd
Australian Respiratory and Sleep Medicine Institute; Cinnagen

Active, not recruiting

Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine

COVID-19

Australia
Jiangsu HengRui Medicine Co., Ltd.
Peking University Cancer Hospital & Institute

Completed

A Study of Fluzoparib Given in Combination With Apatinib in Ovarian or Breast Cancer Patients

Ovarian Cancer | Triple Negative Breast Cancer

China
Shandong Cancer Hospital and Institute
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Hypofraction Radiotherapy in Patients With NSCLC

Non-Small-Cell Lung Cancer

China
Guangzhou Institute of Respiratory Disease
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Efficacy and Safety of Apatinib as Third-line Therapy for Primary Pulmonary Lymphoepithelioid Carcinoma (Spark-AL003)

Lung Carcinoma

China
Jiangsu HengRui Medicine Co., Ltd.
Peking University Cancer Hospital & Institute

Recruiting

A Phase 1 Study of SHR2554 in Subjects With Relapsed or Refractory Mature Lymphoid Neoplasms

Relapsed or Refractory Mature Lymphoid Neoplasms

China
Shandong Cancer Hospital and Institute
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Jiangsu HengRui Medicine Co., Ltd.
Peking University Cancer Hospital & Institute

Unknown

A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma Patients

Melanoma

China
Peking University Cancer Hospital & Institute
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study of Second-line Treatment With Apatinib After TACE in Advanced Hepatocellular Carcinoma Patients

Hepatocellular Carcinoma

China
Sichuan Cancer Hospital and Research Institute
Jiangsu HengRui Medicine Co., Ltd.

Completed

Maintenance Therapy of Apatinib After Chemoradiotherapy in Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

China
ChroniSense Medical Ltd.
IPPMed, Institute for Pharmacology and Preventive Medicine GmbH

Active, not recruiting

Polso™ Watch Blood Pressure Accuracy With Blood Pressure Change Validation (BP)

Blood Pressure

Germany
Vaxine Pty Ltd
Australian Respiratory and Sleep Medicine Institute; Flinders University

Completed

A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults (FLU003)

Influenza

Australia
Sichuan Cancer Hospital and Research Institute
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC

Neoplasms | Respiratory Tract Diseases | Lung Diseases | Thoracic Neoplasms | Non-small-cell Lung Cancer

China
Sichuan Cancer Hospital and Research Institute
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC

Neoplasms | Respiratory Tract Diseases | Lung Diseases | Thoracic Neoplasms | Non-Small-Cell Lung

China
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI); National Institutes of Health (NIH); NovoCure...

Recruiting

WBSI Guided Personalized Delivery of TTFields

GBM | Tumor, Brain | Glioma Glioblastoma Multiforme

United States
Yongsheng Wang
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy

Locally Advanced Breast Cancer | Hormone Receptor Positive，HER2-negative Breast Cancer

China
Tianjin Medical University Cancer Institute and...
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Conversion Therapy of Camrelizumab Plus Chemoradiotherapy in Participants With Initial Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Gastric Cancer
Ross University School of Veterinary Medicine
Serum Institute of India Pvt. Ltd.

Completed

Non-specific Effects of Rabies Vaccine

Diarrhea | Fever | Influenza-like Illness | Upper Respiratory Disease

Saint Kitts and Nevis
Tianjin Medical University Cancer Institute and...
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Study of Camrelizumab Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)

Triple Negative Breast Cancer

China
Tianjin Medical University Cancer Institute and...
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

A Study of SHR6390 Combined With Famitinib in the Treatment of HR + / HER2- Advanced Breast Cancer.

Advanced Breast Cancer | Metastatic Breast Cancer

China
Guangzhou Institute of Respiratory Disease
Jiangsu HengRui Medicine Co., Ltd.; BGI-Shenzhen

Completed

Efficacy of Neoadjuvant PD-1 Blockade Plus Chemotherapy for Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma | Immunotherapy

China
Jinming Yu
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Phase Ⅱ Trial of Pyrotinib Combination With CDK4/6 Inhibitor SHR6390 in Patients Prior Trastuzumab-treated Advanced HER2-Positive Breast Cancer (INPHASE)

Metastatic Breast Cancer | HER2-positive Breast Cancer

China
Tianjin Medical University Cancer Institute and...
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC

Esophageal Cancer

China
Tianjin Medical University Cancer Institute and...
Jiangsu HengRui Medicine Co., Ltd.

Completed

SHR6390 Combined With Anastrozole for Preoperative Treatment of Breast Cancer.

Breast Cancer

China
Tianjin Medical University Cancer Institute and...
Jiangsu HengRui Medicine Co., Ltd.

Completed

Combination of Radiotherapy and SHR-1210 to Treat Patients With ESCC

Esophageal Cancer

China
Ross University School of Veterinary Medicine
Serum Institute of India Pvt. Ltd.

Completed

Safety of Rabivax-S for Pre-exposure Prophylaxis

Rabies Vaccine Adverse Reaction

Saint Kitts and Nevis
Nanjing NingQi Medicine Science and Technology...
Jiangsu Cancer Institute & Hospital

Unknown

Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study

Peripheral T-cell Lymphomas

China

Clinical Trials Sponsored by Medcin Instituto da Pele Ltda

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations